摘要
原文 | 英語 |
---|---|
頁(從 - 到) | 5927-5939 |
頁數 | 13 |
期刊 | Clinical Cancer Research |
卷 | 19 |
發行號 | 21 |
DOIs | |
出版狀態 | 已發佈 - 2013 |
對外發佈 | 是 |
指紋
深入研究「A negative feedback of the HIF-1α pathway via interferon-stimulated gene 15 and ISGylation」主題。共同形成了獨特的指紋。引用此
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
於: Clinical Cancer Research, 卷 19, 編號 21, 2013, p. 5927-5939.
研究成果: 雜誌貢獻 › 文章 › 同行評審
}
TY - JOUR
T1 - A negative feedback of the HIF-1α pathway via interferon-stimulated gene 15 and ISGylation
AU - Yeh, Yen-Hsiu
AU - Yang, Yu-Chen
AU - Hsieh, Mei-Yi
AU - Yeh, Yen-Cheng
AU - Li, Tsai-Kun
N1 - 被引用次數:1 Export Date: 7 April 2016 CODEN: CCREF 通訊地址: Li, T.-K.; Department and Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan; 電子郵件: [email protected] 化學物質/CAS: deferoxamine, 70-51-9; ubiquitin, 60267-61-0 參考文獻: Kerscher, O., Felberbaum, R., Hochstrasser, M., Modification of proteins by ubiquitin and ubiquitin-like proteins (2006) Annu Rev Cell Dev Biol, 22, pp. 159-180; Huang, L.E., Gu, J., Schau, M., Bunn, H.F., Regulation of hypoxia-inducible factor 1alpha is mediated by anO2-dependent degradation domain via the ubiquitin-proteasome pathway (1998) Proc Natl Acad Sci U S A, 95, pp. 7987-7992; Tanimoto, K., Makino, Y., Pereira, T., Poellinger, L., Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein (2000) EMBO J, 19, pp. 4298-4309; Sgorbissa, A., Brancolini, C., IFNs ISGylation and cancer: Cui prodest? (2012) Cytokine Growth Factor Rev, 23, pp. 307-314; Palazon, A., Aragones, J., Morales-Kastresana, A., De Landazuri, M.O., Melero, I., Molecular pathways: Hypoxia response in immune cells fighting or promoting cancer (2012) Clin Cancer Res, 18, pp. 1207-1213; Jeon, Y.J., Jo, M.G., Yoo, H.M., Hong, S.H., Park, J.M., Ka, S.H., Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15 (2012) J Clin Invest, 122, pp. 2622-2636; Desai, S.D., Wood, L.M., Tsai, Y.C., Hsieh, T.S., Marks, J.R., Scott, G.L., ISG15 as a novel tumor biomarker for drug sensitivity (2008) Mol Cancer Ther, 7, pp. 1430-1439; Malakhova, O.A., Yan, M., Malakhov, M.P., Yuan, Y., Ritchie, K.J., Kim, K.I., Protein ISGylation modulates the JAK-STAT signaling pathway (2003) Genes Dev, 17, pp. 455-460; Yuan, W.C., Lee, Y.R., Huang, S.F., Lin, Y.M., Chen, T.Y., Chung, H.C., A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression (2011) Cancer Cell, 20, pp. 214-228; Eltzschig, H.K., Carmeliet, P., Hypoxia and inflammation (2011) N Engl J Med, 364, pp. 656-665; Hanahan, D., Weinberg, R.A., Hallmarks of cancer: The next generation (2011) Cell, 144, pp. 646-674; Mantovani, A., Allavena, P., Sica, A., Balkwill, F., Cancer-related inflammation (2008) Nature, 454, pp. 436-444; Colotta, F., Allavena, P., Sica, A., Garlanda, C., Mantovani, A., Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability (2009) Carcinogenesis, 30, pp. 1073-1081; Meijer, T.W., Kaanders, J.H., Span, P.N., Bussink, J., Targeting hypoxia, HIF- 1, and tumor glucose metabolism to improve radiotherapy efficacy (2012) Clin Cancer Res, 18, pp. 5585-5594; Jaakkola, P., Mole, D.R., Tian, Y.M., Wilson, M.I., Gielbert, J., Gaskell, S.J., Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation (2001) Science, 292, pp. 468-472; Lando, D., Peet, D.J., Gorman, J.J., Whelan, D.A., Whitelaw, M.L., Bruick, R.K., FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor (2002) Genes Dev, 16, pp. 1466-1471; Yin, S., Kaluz, S., Devi, N.S., Jabbar, A.A., De Noronha, R.G., Mun, J., Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1alpha interaction with cofactors p300/CBP (2012) Clin Cancer Res, 18, pp. 6623-6633; Wang, G.L., Jiang, B.H., Rue, E.A., Semenza, G.L., Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension (1995) Proc Natl Acad Sci U S A, 92, pp. 5510-5514; Lang, K.J., Kappel, A., Goodall, G.J., Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia (2002) Mol Biol Cell, 13, pp. 1792-1801; Liu, L.P., Ho, R.L., Chen, G.G., Lai, P.B., Sorafenib inhibits hypoxia-inducible factor-1alpha synthesis: Implications for antiangiogenic activity in hepatocellular carcinoma (2012) Clin Cancer Res, 18, pp. 5662-5671; Dorniak, P., Bazer, F.W., Wu, G., Spencer, T.E., Conceptus-derived prostaglandins regulate endometrial function in sheep (2012) Biol Reprod, 87 (9), pp. 1-7; Song, G., Kim, J., Bazer, F.W., Spencer, T.E., Progesterone and interferon tau regulate hypoxia-inducible factors in the endometrium of the ovine uterus (2008) Endocrinology, 149, pp. 1926-1934; Taylor, C.T., Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation (2008) J Physiol, 586, pp. 4055-4059; Haas, A.L., Ahrens, P., Bright, P.M., Ankel, H., Interferon induces a 15- kilodalton protein exhibiting marked homology to ubiquitin (1987) J Biol Chem, 262, pp. 11315-11323; Weichselbaum, R.R., Ishwaran, H., Yoon, T., Nuyten, D.S., Baker, S.W., Khodarev, N., An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer (2008) Proc Natl Acad Sci U S A, 105, pp. 18490-18495; Andersen, J.B., Aaboe, M., Borden, E.C., Goloubeva, O.G., Hassel, B.A., Orntoft, T.F., Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer (2006) Br J Cancer, 94, pp. 1465-1471; Andersen, J.B., Hassel, B.A., The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: Friend or foe? (2006) Cytokine Growth Factor Rev, 17, pp. 411-421; Kiessling, A., Hogrefe, C., Erb, S., Bobach, C., Fuessel, S., Wessjohann, L., Expression, regulation and function of the ISGylation system in prostate cancer (2009) Oncogene, 28, pp. 2606-2620; Huang, P.Y., Guo, J.H., Hwang, L.H., Oncolytic Sindbis virus targets tumors defective in the interferon response and induces significant bystander antitumor immunity in vivo (2012) Mol Ther, 20, pp. 298-305; Critchley-Thorne, R.J., Simons, D.L., Yan, N., Miyahira, A.K., Dirbas, F.M., Johnson, D.L., Impaired interferon signaling is a common immune defect in human cancer (2009) Proc Natl Acad Sci U S A, 106, pp. 9010-9015; Atzpodien, J., Kirchner, H., Jonas, U., Bergmann, L., Schott, H., Heynemann, H., Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: A Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN) (2004) J Clin Oncol, 22, pp. 1188-1194; Knight Jr., E., Fahey, D., Cordova, B., Hillman, M., Kutny, R., Reich, N., A 15-kDa interferon-induced protein is derived by COOH-terminal processing of a 17-kDa precursor (1988) J Biol Chem, 263, pp. 4520-4522; Wong, J.J., Pung, Y.F., Sze, N.S., Chin, K.C., HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type i IFN-induced ISGylation of protein targets (2006) Proc Natl Acad Sci U S A, 103, pp. 10735-10740; Zhao, C., Beaudenon, S.L., Kelley, M.L., Waddell, M.B., Yuan, W., Schulman, B.A., The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein (2004) Proc Natl Acad Sci U S A, 101, pp. 7578-7582; Desai, S.D., Haas, A.L., Wood, L.M., Tsai, Y.C., Pestka, S., Rubin, E.H., Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway (2006) Cancer Res, 66, pp. 921-928; Huang, Y.F., Chang, M.D., Shieh, S.Y., TTK/hMps1 mediates the p53- dependent postmitotic checkpoint by phosphorylating p53 at Thr18 (2009) Mol Cell Biol, 29, pp. 2935-2944; Yeh, Y.H., Huang, Y.F., Lin, T.Y., Shieh, S.Y., The cell cycle checkpoint kinase CHK2 mediates DNA damage-induced stabilization of TTK/hMps1 (2009) Oncogene, 28, pp. 1366-1378; Okumura, F., Zou, W., Zhang, D.E., ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP (2007) Genes Dev, 21, pp. 255-260; Yang, M.H., Wu, M.Z., Chiou, S.H., Chen, P.M., Chang, S.Y., Liu, C.J., Direct regulation of TWIST by HIF-1alpha promotes metastasis (2008) Nat Cell Biol, 10, pp. 295-305; Koh, M.Y., Powis, G., HAF: The new player in oxygen-independent HIF- 1alpha degradation (2009) Cell Cycle, 8, pp. 1359-1366; Cheng, J., Kang, X., Zhang, S., Yeh, E.T., SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia (2007) Cell, 131, pp. 584-595; D'Angelo, G., Duplan, E., Boyer, N., Vigne, P., Frelin, C., Hypoxia up-regulates prolyl hydroxylase activity: A feedback mechanism that limits HIF-1 responses during reoxygenation (2003) J Biol Chem, 278, pp. 38183-38187; Stiehl, D.P., Wirthner, R., Koditz, J., Spielmann, P., Camenisch, G., Wenger, R.H., Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygensensing system (2006) J Biol Chem, 281, pp. 23482-23491; Bakker, W.J., Harris, I.S., Mak, T.W., FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2 (2007) Mol Cell, 28, pp. 941-953; Bhattacharya, S., Michels, C.L., Leung, M.K., Arany, Z.P., Kung, A.L., Livingston, D.M., Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1 (1999) Genes Dev, 13, pp. 64-75; Henze, A.T., Acker, T., Feedback regulators of hypoxia-inducible factors and their role in cancer biology (2010) Cell Cycle, 9, pp. 2749-2763; Tan, M., Gu, Q., He, H., Pamarthy, D., Semenza, G.L., Sun, Y., SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1 alpha ubiquitination and degradation (2008) Oncogene, 27, pp. 1404-1411; Marxsen, J.H., Stengel, P., Doege, K., Heikkinen, P., Jokilehto, T., Wagner, T., Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases (2004) Biochem J, 381, pp. 761-767; Kim, M.J., Hwang, S.Y., Imaizumi, T., Yoo, J.Y., Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation (2008) J Virol, 82, pp. 1474-1483; Leite De Oliveira, R., Deschoemaeker, S., Henze, A.T., Debackere, K., Finisguerra, V., Takeda, Y., Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity (2012) Cancer Cell, 22, pp. 263-277
PY - 2013
Y1 - 2013
N2 - Purpose: The IFN-stimulated gene 15 (ISG15)- and ubiquitin-conjugation pathways play roles in mediating hypoxic and inflammatory responses. To identify interaction(s) between these two tumor microenvironments, we investigated the effect of ISG15 on the activity of the master hypoxic transcription factor HIF-1α. Experimental Design: IFN and desferoxamine treatments were used to induce the expression of ISGs and HIF-1α, respectively. Interactions between HIF-1α and the ISG15 and ISGylation system were studied using knockdown of mRNA expression, immunoblotting, coimmunoprecipitation, and pull-down analyses. Effects of the ISG15 and ISGylation system on the HIF-1α-directed processes were examined using reporter, reverse transcription polymerase chain reaction (RT-PCR), and tumorigenic growth assays. Results: We found that the level of the free form of HIF-1α is differentially regulated by IFN treatment, and that the free ISG15 level is lower under hypoxia. Mechanism-directed studies have shown that HIF-1α not only interacts physically with ISG15, but is also ISGylated in multiple domains. ISG15 expression disrupts the functional dimerization of HIF-1α and -1β. Subsequently, expression of the ISG15 and/or ISGylation system attenuates HIF-1α-mediated gene expression and tumorigenic growth. Conclusion: In summary, our results revealed cross-talk between inflammatory and hypoxic pathways through the ISGylation of HIF-1α. On the basis of these results, we propose a novel negative feedback loop for the HIF-1α-mediated pathway involving the regulation of HIF-1α via IFN-induced ISGylation. © 2013 American Association for Cancer Research.
AB - Purpose: The IFN-stimulated gene 15 (ISG15)- and ubiquitin-conjugation pathways play roles in mediating hypoxic and inflammatory responses. To identify interaction(s) between these two tumor microenvironments, we investigated the effect of ISG15 on the activity of the master hypoxic transcription factor HIF-1α. Experimental Design: IFN and desferoxamine treatments were used to induce the expression of ISGs and HIF-1α, respectively. Interactions between HIF-1α and the ISG15 and ISGylation system were studied using knockdown of mRNA expression, immunoblotting, coimmunoprecipitation, and pull-down analyses. Effects of the ISG15 and ISGylation system on the HIF-1α-directed processes were examined using reporter, reverse transcription polymerase chain reaction (RT-PCR), and tumorigenic growth assays. Results: We found that the level of the free form of HIF-1α is differentially regulated by IFN treatment, and that the free ISG15 level is lower under hypoxia. Mechanism-directed studies have shown that HIF-1α not only interacts physically with ISG15, but is also ISGylated in multiple domains. ISG15 expression disrupts the functional dimerization of HIF-1α and -1β. Subsequently, expression of the ISG15 and/or ISGylation system attenuates HIF-1α-mediated gene expression and tumorigenic growth. Conclusion: In summary, our results revealed cross-talk between inflammatory and hypoxic pathways through the ISGylation of HIF-1α. On the basis of these results, we propose a novel negative feedback loop for the HIF-1α-mediated pathway involving the regulation of HIF-1α via IFN-induced ISGylation. © 2013 American Association for Cancer Research.
KW - deferoxamine
KW - hypoxia inducible factor 1alpha
KW - hypoxia inducible factor 1beta
KW - interferon
KW - interferon stimulated gene 15 protein
KW - messenger RNA
KW - ubiquitin
KW - unclassified drug
KW - animal experiment
KW - animal model
KW - article
KW - cell hypoxia
KW - cell proliferation
KW - controlled study
KW - dimerization
KW - gene expression
KW - human
KW - human cell
KW - immunoblotting
KW - immunoprecipitation
KW - inflammation
KW - ISGylation
KW - mouse
KW - negative feedback
KW - nonhuman
KW - priority journal
KW - protein domain
KW - protein processing
KW - protein protein interaction
KW - reverse transcription polymerase chain reaction
KW - tumor growth
KW - tumor xenograft
KW - Anoxia
KW - Cell Line, Tumor
KW - Cell Proliferation
KW - Cell Transformation, Neoplastic
KW - Cytokines
KW - Gene Expression Regulation
KW - Humans
KW - Hypoxia-Inducible Factor 1, alpha Subunit
KW - Interferons
KW - Protein Binding
KW - Protein Interaction Domains and Motifs
KW - Response Elements
KW - Signal Transduction
KW - Ubiquitins
U2 - 10.1158/1078-0432.CCR-13-0018
DO - 10.1158/1078-0432.CCR-13-0018
M3 - Article
SN - 1078-0432
VL - 19
SP - 5927
EP - 5939
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 21
ER -